Teresa Aldamiz

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.

Breaking barriers: Implementation of a tuberculosis preventive treatment protocol among newly eligible populations with promising results.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: October 17, 2025

Q fever transmission mediated by ticks.

Q fever transmission mediated by ticks.

Journal: Emerging microbes & infections

Published: October 08, 2025

Evaluation of the efficiency of combined antiviral therapy in COVID-19 challenging immunocompromised patients.

Evaluation of the efficiency of combined antiviral therapy in COVID-19 challenging immunocompromised patients.

Journal: Scientific reports

Published: October 01, 2025

Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient.

Chronic Systemic SARS-CoV-2 Infection Without Respiratory Involvement in an Immunocompromised Patient.

Journal: Viruses

Published: December 19, 2024

The incidence of HIV-2 infection in Spain is declining - a registry data analysis.

The incidence of HIV-2 infection in Spain is declining - a registry data analysis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: March 03, 2024

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.

Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.

Journal: Journal of cancer research and clinical oncology

Published: July 25, 2023

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.

IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors.

Journal: Frontiers in immunology

Published: July 12, 2023

Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg.

Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 17, 2023

Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital.

Cytomegalovirus reactivation in patients diagnosed with severe COVID-19: A point prevalence study in a general hospital.

Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia

Published: November 21, 2022

Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.

Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implications.

Journal: Histopathology

Published: February 21, 2022

Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.

Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study.

Journal: Medicine

Published: November 12, 2021

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19.

Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19.

Journal: BMC infectious diseases

Published: November 01, 2020

Showing 1-12 of 16

Last Updated: 09/26/2026